IL108091A - Usable amino acid derivatives as intermediate compounds in the synthesis of protease VIH inhibitors - Google Patents

Usable amino acid derivatives as intermediate compounds in the synthesis of protease VIH inhibitors

Info

Publication number
IL108091A
IL108091A IL108091A IL10809193A IL108091A IL 108091 A IL108091 A IL 108091A IL 108091 A IL108091 A IL 108091A IL 10809193 A IL10809193 A IL 10809193A IL 108091 A IL108091 A IL 108091A
Authority
IL
Israel
Prior art keywords
reaction
amino
mmol
acid
butyl
Prior art date
Application number
IL108091A
Other languages
English (en)
Hebrew (he)
Other versions
IL108091A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL108091A0 publication Critical patent/IL108091A0/xx
Publication of IL108091A publication Critical patent/IL108091A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL108091A 1992-12-22 1993-12-20 Usable amino acid derivatives as intermediate compounds in the synthesis of protease VIH inhibitors IL108091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/994,871 US5434265A (en) 1992-12-22 1992-12-22 Inhibitors of HIV protease

Publications (2)

Publication Number Publication Date
IL108091A0 IL108091A0 (en) 1994-04-12
IL108091A true IL108091A (en) 1998-04-05

Family

ID=25541167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL108091A IL108091A (en) 1992-12-22 1993-12-20 Usable amino acid derivatives as intermediate compounds in the synthesis of protease VIH inhibitors

Country Status (24)

Country Link
US (2) US5434265A (hu)
EP (1) EP0604183B1 (hu)
JP (1) JPH07179417A (hu)
KR (1) KR940014335A (hu)
CN (1) CN1098407A (hu)
AT (1) ATE149488T1 (hu)
AU (1) AU667593B2 (hu)
BR (1) BR9305164A (hu)
CA (1) CA2112041A1 (hu)
CZ (1) CZ281693A3 (hu)
DE (1) DE69308514T2 (hu)
DK (1) DK0604183T3 (hu)
ES (1) ES2101252T3 (hu)
FI (1) FI935777A (hu)
GR (1) GR3023457T3 (hu)
HU (1) HUT70748A (hu)
IL (1) IL108091A (hu)
MX (1) MX9308005A (hu)
NO (1) NO301005B1 (hu)
NZ (1) NZ250492A (hu)
PL (1) PL301576A1 (hu)
TW (1) TW280813B (hu)
YU (1) YU79693A (hu)
ZA (1) ZA939476B (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
CA2130754C (en) 1992-03-11 2005-02-08 Damian W. Grobelny Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
DE4439193A1 (de) * 1994-11-03 1996-05-09 Bayer Ag Mischung zur Korrosionshemmung von Metallen
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
CA2179935C (en) * 1995-06-30 2010-09-07 Ryohei Kato Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
CA2238175A1 (en) * 1995-11-28 1997-06-19 Cephalon, Inc. D-amino acid derived inhibitors of cysteine and serine proteases
WO1997028105A1 (en) * 1996-01-29 1997-08-07 Kaneka Corporation Processes for the reduction of carbonyl compounds
US5705647A (en) * 1996-09-05 1998-01-06 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US5962725A (en) 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5925759A (en) 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
CA2249747A1 (en) 1996-12-27 1998-07-09 Tsutomu Mimoto Novel tripeptide compounds and anti-aids drugs
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US6084107A (en) * 1997-09-05 2000-07-04 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US6096778A (en) 1997-10-07 2000-08-01 Cephalon, Inc. α-ketoamide multicatalytic protease inhibitors
US6083944A (en) * 1997-10-07 2000-07-04 Cephalon, Inc. Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
US6150378A (en) 1997-10-07 2000-11-21 Cephalon, Inc. Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
WO2000002862A1 (en) * 1998-07-08 2000-01-20 G.D. Searle & Co. Retroviral protease inhibitors
WO2007059311A2 (en) * 2005-11-16 2007-05-24 Nitromed, Inc. Furoxan compounds, compositions and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) * 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
EP0361341A3 (en) * 1988-09-28 1991-07-03 Miles Inc. Therapeutics for aids based on inhibitors of hiv protease
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
HU9301447D0 (en) * 1990-11-19 1993-11-29 Monsanto Co Inhibitors of retrovirus protease
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂
US5516784A (en) * 1991-08-13 1996-05-14 Schering Corporation Anti-HIV (AIDS) agents
US5491166A (en) * 1992-12-22 1996-02-13 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS

Also Published As

Publication number Publication date
EP0604183B1 (en) 1997-03-05
EP0604183A1 (en) 1994-06-29
ATE149488T1 (de) 1997-03-15
HUT70748A (en) 1995-10-30
ES2101252T3 (es) 1997-07-01
NO934718L (no) 1994-06-23
KR940014335A (ko) 1994-07-18
DE69308514T2 (de) 1997-07-10
MX9308005A (es) 1994-08-31
CN1098407A (zh) 1995-02-08
BR9305164A (pt) 1994-11-01
TW280813B (hu) 1996-07-11
FI935777A (fi) 1994-06-23
CZ281693A3 (en) 1994-07-13
US5514802A (en) 1996-05-07
NO934718D0 (no) 1993-12-20
DE69308514D1 (de) 1997-04-10
US5434265A (en) 1995-07-18
DK0604183T3 (da) 1997-05-26
YU79693A (sh) 1997-07-31
AU667593B2 (en) 1996-03-28
NZ250492A (en) 1995-08-28
IL108091A0 (en) 1994-04-12
NO301005B1 (no) 1997-09-01
HU9303680D0 (en) 1994-04-28
FI935777A0 (fi) 1993-12-21
AU5253093A (en) 1994-07-07
GR3023457T3 (en) 1997-08-29
CA2112041A1 (en) 1994-06-23
JPH07179417A (ja) 1995-07-18
ZA939476B (en) 1995-06-19
PL301576A1 (en) 1994-06-27

Similar Documents

Publication Publication Date Title
US5905077A (en) Inhibitors of HIV protease useful for the treatment of AIDS
US5502061A (en) Peptidyl substituted benzamides and naphthamies
US5434265A (en) Inhibitors of HIV protease
US5719287A (en) Intermediates for inhibitors of HIV protease and method of preparation thereof
US5554653A (en) Inhibitors of HIV protease useful for the treatment of AIDS
US5578608A (en) Symmetrical diaryl and diheteroanyl cis epoxy alkanes antiviral compounds
US5733906A (en) Inhibitors of HIV Protease useful for the treatment of Aids
EP0609625A1 (en) Inhibitors of HIV protease useful for the treatment of AIDS
US5491166A (en) Inhibitors of HIV protease useful for the treatment of AIDS
US5461154A (en) Intermediate and process for making
US5475136A (en) Inhibitors of HIV protease useful for the treatment of AIDS

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void